US 9302015
Anti-PRLR antibodies and methods for killing PRLR-expressing cells
granted A61KA61K2039/505A61K31/537
Quick answer
US patent 9302015 (Anti-PRLR antibodies and methods for killing PRLR-expressing cells) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 57
- CPC classes
- A61K, A61K2039/505, A61K31/537, A61K47/68031, A61K47/68033